말초혈 단핵세포 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측, 제품별, 용도별, 기술별, 공급원별, 지역별, 경쟁별(2020-2030년)
Peripheral Blood Mononuclear Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Techniques, By Source, By Region and Competition, 2020-2030F
상품코드:1807147
리서치사:TechSci Research
발행일:2025년 08월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 말초혈 단핵세포 시장은 2024년에는 2억 8,089만 달러로 평가되었고, 예측 기간 중 CAGR은 10.02%를 나타내, 2030년에는 4억 9,602만 달러에 이를 것으로 예상되고 있습니다.
세계의 말초혈 단핵세포 시장은 세포 요법 수 증가율, 독성 시험을 위한 연구 개발 수요의 높이, 제품의 신규 안정 개발을 담당하는 화합물의 반응 메커니즘에 의해 큰 성장을 이루고 있습니다. 예를 들어, 2023년 6월에 National Library of Medicine에 게재된 연구에서는 트리파노소마 크루지(Trypanosoma cruzi)의 콜롬비아 균주(Col)에 시험관 내에서 감염시키고, 벤조니다졸로 처리한 말초혈 단핵세포(PBMC)의 면역 반응을 평가했습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
2억 8,089만 달러
시장 규모 : 2030년
4억 9,602만 달러
CAGR : 2025-2030년
10.02%
급성장 부문
면역학
최대 시장
북미
시장 성장 촉진요인
정부 자금에 의한 세포 요법과 면역학 연구
주요 시장 과제
규제 및 품질 규정 준수의 복잡성
주요 시장 동향
백신 개발 및 면역 모니터링에서의 역할 확대
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 COVID-19가 세계의 말초혈 단핵세포 시장에 미치는 영향
제5장 고객의 목소리
제6장 세계의 말초혈 단핵세포 시장 전망
시장 규모와 예측
금액별
시장 점유율·예측
제품별(냉동 보존 또는 냉동 말초혈 단핵세포, 배양 또는 신선한 말초혈 단핵세포, 말초혈 단핵세포 분리 및 생존율 키트)
용도별(면역학, 감염성 질환, 혈액학, 기타)
기술별(밀도 구배 원심분리법 및 백혈구 채혈법)
발생원별(인간 및 동물)
지역별(북미, 유럽, 아시아태평양, 남미, 중동 및 아프리카)
기업별(2024년)
시장 맵
제품별
용도별
기술별
발생원별
지역별
제7장 북미의 말초혈 단핵세포 시장 전망
시장 규모와 예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제8장 유럽의 말초혈 단핵세포 시장 전망
시장 규모와 예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제9장 아시아태평양의 말초혈 단핵세포 시장 전망
시장 규모와 예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
일본
인도
한국
호주
제10장 남미의 말초혈 단핵세포 시장 전망
시장 규모와 예측
시장 점유율·예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제11장 중동 및 아프리카의 말초혈 단핵세포 시장 전망
시장 규모와 예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
아랍에미리트(UAE)
사우디아라비아
남아프리카
제12장 시장 역학
성장 촉진요인
과제
제13장 시장 동향과 발전
합병과 인수
제품 출시
최근 동향
제14장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협/서비스
제15장 SWOT 분석 : 세계의 말초혈 단핵세포 시장
제16장 임상시험 분석
제17장 경쟁 구도
Charles River Laboratories International, Inc.
Lonza Group AG
Corning Inc.
Bio-Rad Laboratories Inc.
ABCAM
Biolegend Inc.
ZEN-Bio Inc.
DAPCEL, Inc.
Creative Bioarray
iXCells Biotechnologies USA, LLC
제18장 전략적 제안
제19장 기업 소개와 면책사항
KTH
영문 목차
영문목차
Global Peripheral Blood Mononuclear Cells Market was valued at USD 280.89 million in 2024 and is expected to reach USD 496.02 million by 2030 with a CAGR of 10.02% during the forecast period. The global market for Peripheral Blood Mononuclear Cells is experiencing significant growth, driven by the rising rate in number of cell therapies, high demand of research and development for toxicology testing and reaction mechanism of the compound responsible for new and stable development of products. For instance, in June 2023, a study published in National Library of Medicine, it assessed the immune response of peripheral blood mononuclear cells (PBMC) that were infected in vitro with the Colombian strain (Col) of Trypanosoma cruzi and treated with Benzonidazole.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 280.89 Million
Market Size 2030
USD 496.02 Million
CAGR 2025-2030
10.02%
Fastest Growing Segment
Immunology
Largest Market
North America
Key Market Drivers
Government-Funded Cell Therapy and Immunology Research
Governments worldwide are significantly increasing investments in cell and gene therapy, where PBMCs play a critical role. In the U.S., the National Institutes of Health (NIH) continues to back programs-such as immuno-oncology and vaccine research-that rely heavily on PBMC-based assays to characterize immune responses before and after experimental treatments. NIH-funded vaccine programs studying T-cell immunity routinely isolate PBMCs from donors to quantify immunogenicity in clinical testing. Similarly, in Europe, the Innovative Medicines Initiative (IMI)-a €2 billion public-private partnership co-funded by the European Commission-supports drug development platforms that use PBMC-based biomarker identification and immune monitoring in early-phase clinical trials. This large-scale public-sector support for PBMC-integrated therapeutics research underlines PBMCs' indispensable role in translational medicine and offers a robust, policy-backed driver for market expansion.
Key Market Challenges
Regulatory and Quality Compliance Complexity
A significant challenge arises from the stringent and fragmented regulatory frameworks governing PBMC collection, processing, and distribution across jurisdictions. In the European Union, PBMC isolation facilities must conform to EU Tissue and Cells Directives (EUTCD) as well as national regulatory agency audits (e.g., Germany's Paul-Ehrlich-Institut), with repeat compliance checks and data privacy enforcement under GDPR-violations can incur fines exceeding €20 million. In China, PBMC processing kits are treated as Class III medical devices requiring clinical validation, and export of PBMC samples with human genetic information is restricted under the 2021 Biosecurity Law, mandating dual approvals from NMPA and the Ministry of Commerce. These variable, complex regulations raise costs for cross-border research and discourage adoption in regions without harmonized oversight, inhibiting global standardization and scalable PBMC usage.
Key Market Trends
Expanding Role in Vaccine Development and Immuno-Monitoring
A rapidly emerging trend is the expanded application of PBMCs for vaccine research and immunogenicity evaluation, especially in government-backed vaccine rollouts and pandemic preparedness. PBMCs offer critical insight into T-cell responses, cytokine profiles, and durability of immune memory. Governments funding large-scale vaccine trials-for diseases like COVID-19, malaria, tuberculosis-routinely incorporate PBMC-based assays into protocols to evaluate safety and immune efficacy. This creates predictable public-sector demand for standardized PBMC isolation, storage, and testing services, accelerating market growth tied to national immunization programs.
Key Market Players
Charles River Laboratories International, Inc.
Lonza Group AG
Corning Inc.
Bio-Rad Laboratories Inc.
ABCAM
Biolegend Inc.
ZEN-Bio Inc.
DAPCEL, Inc.
Creative Bioarray
iXCells Biotechnologies USA, LLC
Report Scope:
In this report, the Global Peripheral Blood Mononuclear Cells Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Peripheral Blood Mononuclear Cells Market, By Product:
Peripheral Blood Mononuclear Cells Market, By Application:
Immunology
Infectious Disease
Hematology
Others
Peripheral Blood Mononuclear Cells Market, By Technique:
Density Gradient Centrifugation Process
Leukapheresis
Peripheral Blood Mononuclear Cells Market, By Source:
Human
Animals
Peripheral Blood Mononuclear Cells Market, By Region:
North America
United States
Mexico
Canada
Europe
France
Germany
United Kingdom
Italy
Spain
Asia-Pacific
China
India
South Korea
Japan
Australia
South America
Brazil
Argentina
Colombia
Middle East and Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Peripheral Blood Mononuclear Cells Market.
Available Customizations:
Global Peripheral Blood Mononuclear Cells Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on Global Peripheral Blood Mononuclear Cells Market
5. Voice of Customer
6. Global Peripheral Blood Mononuclear Cells Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC and Peripheral Blood Mononuclear Cell Isolation & Viability Kits)
6.2.2. By Application (Immunology, Infectious Disease, Hematology and Others)
6.2.3. By Technique (Density Gradient Centrifugation Process and Leukapheresis)
6.2.4. By Source (Human and Animals)
6.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
6.2.6. By Company (2024)
6.3. Market Map
6.3.1. By Product
6.3.2. By Application
6.3.3. By Technique
6.3.4. By Source
6.3.5. By Region
7. North America Peripheral Blood Mononuclear Cells Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By Technique
7.2.4. By Source
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Peripheral Blood Mononuclear Cells Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By Technique
7.3.1.2.4. By Source
7.3.2. Canada Peripheral Blood Mononuclear Cells Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By Technique
7.3.2.2.4. By Source
7.3.3. Mexico Peripheral Blood Mononuclear Cells Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By Technique
7.3.3.2.4. By Source
8. Europe Peripheral Blood Mononuclear Cells Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By Technique
8.2.4. By Source
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Peripheral Blood Mononuclear Cells Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By Technique
8.3.1.2.4. By Source
8.3.2. France Peripheral Blood Mononuclear Cells Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By Technique
8.3.2.2.4. By Source
8.3.3. United Kingdom Peripheral Blood Mononuclear Cells Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By Technique
8.3.3.2.4. By Source
8.3.4. Italy Peripheral Blood Mononuclear Cells Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By Technique
8.3.4.2.4. By Source
8.3.5. Spain Peripheral Blood Mononuclear Cells Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By Technique
8.3.5.2.4. By Source
9. Asia-Pacific Peripheral Blood Mononuclear Cells Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By Technique
9.2.4. By Source
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Peripheral Blood Mononuclear Cells Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By Technique
9.3.1.2.4. By Source
9.3.2. Japan Peripheral Blood Mononuclear Cells Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By Technique
9.3.2.2.4. By Source
9.3.3. India Peripheral Blood Mononuclear Cells Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By Technique
9.3.3.2.4. By Source
9.3.4. South Korea Peripheral Blood Mononuclear Cells Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Application
9.3.4.2.3. By Technique
9.3.4.2.4. By Source
9.3.5. Australia Peripheral Blood Mononuclear Cells Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product
9.3.5.2.2. By Application
9.3.5.2.3. By Technique
9.3.5.2.4. By Source
10. South America Peripheral Blood Mononuclear Cells Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By Technique
10.2.4. By Source
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Peripheral Blood Mononuclear Cells Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By Technique
10.3.1.2.4. By Source
10.3.2. Argentina Peripheral Blood Mononuclear Cells Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By Technique
10.3.2.2.4. By Source
10.3.3. Colombia Peripheral Blood Mononuclear Cells Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By Technique
10.3.3.2.4. By Source
11. Middle East and Africa Peripheral Blood Mononuclear Cells Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Application
11.2.3. By Technique
11.2.4. By Source
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. UAE Peripheral Blood Mononuclear Cells Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Application
11.3.1.2.3. By Technique
11.3.1.2.4. By Source
11.3.2. Saudi Arabia Peripheral Blood Mononuclear Cells Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Application
11.3.2.2.3. By Technique
11.3.2.2.4. By Source
11.3.3. South Africa Peripheral Blood Mononuclear Cells Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Application
11.3.3.2.3. By Technique
11.3.3.2.4. By Source
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
13.1. Merger & Acquisition (If Any)
13.2. Product Launches (If Any)
13.3. Recent Developments
14. Porters Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products/Services
15. SWOT Analysis: Global Peripheral Blood Mononuclear Cells Market
16. Clinical Trial Analysis
16.1. Ongoing Clinical Trials
16.2. Completed Clinical Trials
16.3. Terminated Clinical Trials
16.4. Breakdown of Pipeline, By Development Phase
16.5. Breakdown of Pipeline, By Status
16.6. Breakdown of Pipeline, By Study Type
16.7. Breakdown of Pipeline, By Region
16.8. Clinical Trials Heat Map
17. Competitive Landscape
17.1. Charles River Laboratories International, Inc.
